Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific | 2022
While the COVID-19 pandemic will have a negative but limited impact on the Asia Pacific transcatheter embolization and occlusion device market in the short term, the market will expand at a strong rate over the forecast period, driven by adoption of innovative and premium-priced products, incremental device improvements, as well as rising penetration of endovascular embolization in new indications.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in the Asia Pacific region across a 11-year period.